Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Analyst Ratings For Allakos
Within the last quarter, Allakos (NASDAQ:ALLK) has observed the following analyst ratings:
SVB Leerink Maintains Market Perform on Allakos, Lowers Price Target to $13
SVB Leerink analyst Thomas Smith maintains Allakos (NASDAQ:ALLK) with a Market Perform and lowers the price target from $17 to $13.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
54 Biggest Movers From Thursday
Gainers
22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of nicotine for smokers who use them.
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating sentiment.
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65.